First gene therapy for a rare eye disease, now NHS-approved
BBC - 17-Feb-2020This life-changing new gene therapy will halt sight loss and improve vision
Join the club for FREE to access the whole archive and other member benefits.
Professor of Ophthalmology at University of Oxford.
Robert MacLaren is Professor of Ophthalmology at the University of Oxford, Consultant Ophthalmologist at the Oxford Eye Hospital, Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology, Honorary Consultant Vitreoretinal Surgeon at Moorfields Eye Hospital and an NIHR Senior Investigator. He is also a Fellow of the Royal College of Ophthalmologists, Fellow and former King James IV Professor of Surgery at the Royal College of Surgeons of Edinburgh, Fellow of the American College of Surgeons, Fellow of the Academy of Medical Sciences, Bodley Fellow of Merton College Oxford and Civilian Consultant Advisor to the Royal Navy. He has been a recipient of the ARVO Camras Award for Translational Research, the RP Fighting Blindness Scientist of the Year Award, the American Academy of Ophthalmology Achievement Award, the Royal College of Ophthalmologists Keeler Medal and the Macular Society Clinical Service of the Year award.
Visit website: https://www.ndcn.ox.ac.uk/team/robert-maclaren
See also: University of Oxford - Collegiate research university and one of the world's leading universities
Details last updated 08-Jan-2020
This life-changing new gene therapy will halt sight loss and improve vision
Successful treatment of retinitis pigmentosa and spinal muscular atrophy
Surgeon controlled robot via a joystick to remove a membrane one hundredth of a millimetre thick....